The miss and guidance cut are likely to pressure ZTS shares near term. Monitor the earnings call for commentary on U.S. demand trends and competitive dynamics. The International segment's organic growth and pipeline remain bright spots, but the core U.S. companion animal weakness is a significant headwind.
Price Chart
Executive Summary
Zoetis Q1 2026 adjusted EPS of $1.53 missed consensus of $1.62 (-5.6%), and FY2026 guidance was lowered to revenue of $9.68-9.96B (from $9.825-10.025B) and adjusted EPS of $6.85-7.00 (from $7.00-7.10). U.S. companion animal revenue fell 11% YoY on weaker demand and competition, partially offset by International growth. The revised outlook signals a more challenging operating environment.
Key Financial Metrics
Key Facts
- Q1 2026 revenue $2.262B, +3% reported, flat organic operational growth
- GAAP diluted EPS $1.42, adjusted diluted EPS $1.53
- Adjusted EPS $1.53 vs consensus $1.62 (miss of 5.6%)
- FY2026 revenue guidance lowered to $9.680-$9.960B from $9.825-$10.025B
- FY2026 adjusted EPS guidance lowered to $6.85-$7.00 from $7.00-$7.10
- U.S. segment revenue fell 8% (companion animal -11%) on price sensitivity and competition
- International segment revenue up 17% reported (10% organic), aided by ~$100M from fiscal year alignment timing
Financial Impact
Adjusted EPS miss of $0.09 vs consensus; FY2026 revenue midpoint reduced by ~$145M; adjusted EPS guidance midpoint reduced by ~$0.13.
Risk Factors
- Continued deterioration in U.S. companion animal demand
- Increased competition in dermatology and parasiticides
- Macroeconomic pressure on pet owner spending
- Execution risk in stabilizing U.S. segment performance
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001555280-26-000021 |
| Document: zts-20260507.htm | 0001555280-26-000021 |
| Document: 0001555280-26-000021-index-headers.html | 0001555280-26-000021 |
| Document: 0001555280-26-000021-index.html | 0001555280-26-000021 |
| Document: 0001555280-26-000021.txt | 0001555280-26-000021 |
| 8-K Data (Synthetic) | 0001555280-26-000021 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 6, 2026 8w ago | 8-K | $77.05 $76.29 | ▲ +0.99% | ▲ +1.58% | $69.10 (+10.32%) |
May 20, 2026 19w ago | 8-K | $79.98 $78.71 | ▼ −1.59% | ▼ −2.13% | $69.10 (−13.60%) |
May 13, 2026 20w ago | Insider Cluster | $75.24 $79.57 | ▲ +5.76% | ▲ +6.61% | $69.10 (−8.16%) |
May 7, 2026 21w ago | 8-K | $87.24 $77.59 | ▲ +11.06% | ▲ +14.20% | $69.10 (+20.79%) |
Apr 8, 2026 25w ago | DEFA14A | $119.65 $112.54 | ▼ −5.94% | ▼ −14.49% | $69.10 (−42.25%) |
Feb 27, 2026 31w ago | Court Ruling | $131.02 $113.27 | ▲ +13.55% | ▲ +5.99% | $69.10 (+47.26%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access